2335 — Shaanxi Micot Pharmaceutical Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$7.96bn
- HK$6.58bn
Annual cashflow statement for Shaanxi Micot Pharmaceutical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2024 December 31st | 2025 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -157 | -185 |
| Depreciation | ||
| Non-Cash Items | 31.7 | 21.6 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | 8.94 | 19.6 |
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -108 | -137 |
| Capital Expenditures | -1.3 | -17 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 56.1 | -40.6 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | 54.8 | -57.6 |
| Financing Cash Flow Items | -0.871 | -30.7 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 21.1 | 212 |
| Foreign Exchange Effects | ||
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -31.3 | 15.9 |